Extended-spectrum antiprotozoal bumped kinase inhibitors: A review

Wesley C. Van Voorhis, J. Stone Doggett, Marilyn Parsons, Matthew A. Hulverson, Ryan Choi, Samuel Arnold, Michael W Riggs, Andrew Hemphill, Daniel K. Howe, Robert H. Mealey, Audrey O T Lau, Ethan A. Merritt, Dustin J. Maly, Erkang Fan, Kayode K. Ojo

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

Many life-cycle processes in parasites are regulated by protein phosphorylation. Hence, disruption of essential protein kinase function has been explored for therapy of parasitic diseases. However, the difficulty of inhibiting parasite protein kinases to the exclusion of host orthologues poses a practical challenge. A possible path around this difficulty is the use of bumped kinase inhibitors for targeting calcium dependent protein kinases that contain atypically small gatekeeper residues and are crucial for pathogenic apicomplexan parasites' survival and proliferation. In this review, we review efficacy against the kinase target, the parasite growth in vitro, and in animal infection models, as well as the relevant pharmacokinetic and safety parameters of bumped-kinase inhibitors.

Original languageEnglish (US)
JournalExperimental Parasitology
DOIs
Publication statusAccepted/In press - 2017

    Fingerprint

Keywords

  • Bumped-kinase inhibitors
  • Calcium-dependent protein kinase
  • Gatekeeper residue

ASJC Scopus subject areas

  • Parasitology
  • Immunology

Cite this

Van Voorhis, W. C., Doggett, J. S., Parsons, M., Hulverson, M. A., Choi, R., Arnold, S., ... Ojo, K. K. (Accepted/In press). Extended-spectrum antiprotozoal bumped kinase inhibitors: A review. Experimental Parasitology. https://doi.org/10.1016/j.exppara.2017.01.001